Prelude Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update GlobeNewswire August 14, 2025 PRT7732, once daily oral SMARCA2 degrader, currently enrolling at the seventh dosing cohort (125 mg); Company to provide an update with preliminary clinical data, including PK/PD, safety and initial clinical activity by year end 2025 Phase 1 study of […]

TeraWulf Signs 200+ MW, 10-Year AI Hosting Agreements with Fluidstack GlobeNewswire August 14, 2025 Further Establishes TeraWulf as a Leading Provider of Hyperscale AI Infrastructure, Backed by Tier 1 Counterparties Transaction Anchors ~$3.7 Billion in Contracted Revenues, with Potential to Reach $8.7 Billion Through Lease Extensions Google Backstops $1.8 Billion of Fluidstack Obligations in Support

Vimo(R) Partners with the State of Wyoming's Department of Family Services to Launch ECARES Child Care Exchange New Integrated System Will Improve Access to Child Care and Streamline Provider Participation GlobeNewswire August 14, 2025 Mountain View, CA, Aug. 14, 2025 (GLOBE NEWSWIRE) — MOUNTAIN VIEW, Calif., August 14, 2025 — Vimo(R), the leader in modernizing

Tilray Brands Reconfirms Strategy to Regain Nasdaq Compliance; Requests Extension to Meet Listing Requirements GlobeNewswire August 14, 2025 NEW YORK and LEAMINGTON, Ontario, Aug. 14, 2025 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle consumer packaged goods company at the forefront of the cannabis, beverage, and

Lungpacer Announces CMS NTAP Approval for AeroPace(R) System in FY2026 IPPS Final Rule GlobeNewswire August 14, 2025 Exton, Pa., Aug. 14, 2025 (GLOBE NEWSWIRE) — Lungpacer Medical Inc., a medical technology company focused on neurostimulation therapies for critically ill patients, today announced that the Centers for Medicare & Medicaid Services (CMS) has granted New Technology

SYLOGIST Reports Second Quarter 2025 Results Strong Bookings and continuing SaaS Revenue growth GlobeNewswire August 14, 2025 Q2 2025 Highlights 1 Revenue (in $ millions) SaaS Subscription Recurring Total Reported Y/Y growth Reported Y/Y growth Reported Y/Y growth $7.9 13.1% $10.9 4.0% $15.7 (6.9)% SaaS ARR up 12.5% Y/Y to $31.7 million; Total ARR up

Balt USA Responds to Patent Infringement Lawsuit Filed by Route 92 Medical GlobeNewswire August 14, 2025 IRVINE, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) — Balt USA, LLC (“Balt”), a global leader in neurovascular medical devices, today announced it intends to vigorously defend against the allegations of patent infringement filed by Route 92 Medical, Inc. against

Infinity Loop Raises $5M; Empowers Enterprises to Save Millions on Vendor Contracts AI-native contract intelligence platform drives 12%+ annual savings, with one customer saving $19.5M in just five months GlobeNewswire August 14, 2025 NEW YORK, Aug. 14, 2025 (GLOBE NEWSWIRE) — Infinity Loop, the AI-native contract intelligence platform built to help enterprises save money on

Larimar Therapeutics Reports Second Quarter 2025 Financial Results GlobeNewswire August 14, 2025 Initial data from the 50 mg dose in the open label study and the adolescent PK run-in study planned for program update in September 2025 Adolescent participants from the PK run-in study and patients with FA who have not participated in prior nomlabofusp

Athira Pharma Presents ATH-1105 Phase 1 Trial Results at ALS Nexus 2025 GlobeNewswire August 14, 2025 BOTHELL, Wash., Aug. 14, 2025 (GLOBE NEWSWIRE) — Athira Pharma, Inc. (NASDAQ: ATHA), a clinical stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, presented results from its Phase 1 clinical trial of